The United States has entered an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential Covid-19 vaccine for around $1.5 billion, the company and White House has said.
The United States has made deals to acquire hundreds of millions of doses of potential Covid-19 vaccines from several companies as part of its ‘Operation Warp Speed’ program, which aims to deliver a vaccine in the country by the end of the year.
Moderna’s price per dose comes to around $30.50 per person for a two-dose regimen.
With the exception of its deal with AstraZeneca, which offered a lower price per drug in exchange for upfront research and development costs, all the deals price Covid-19 vaccines between $20 and $42 for a two-dose course of treatment.
Moderna’s vaccine candidate, mRNA-1273, is one of the few that have already advanced to the final stage of testing and is on track to be completed in September, the company said this month.
Moderna’s deal with the U.S. only pays out in full if the drugmaker hits certain unspecific timing benchmarks for vaccine delivery.